The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pneumonia, Bacterial

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pneumonia, Bacterial


High impact information on Pneumonia, Bacterial


Chemical compound and disease context of Pneumonia, Bacterial


Biological context of Pneumonia, Bacterial

  • Exhaustion of SP-D protein reserves and absence of SP-D gene upregulation during the progression of bacterial pneumonia into chronicity may result in failure to clear the pathogen from the lung and/or cause animals to be more susceptible to re-infection [14].

Anatomical context of Pneumonia, Bacterial


Gene context of Pneumonia, Bacterial


Analytical, diagnostic and therapeutic context of Pneumonia, Bacterial


  1. Unscheduled apoptosis during acute inflammatory lung injury. Mantell, L.L., Kazzaz, J.A., Xu, J., Palaia, T.A., Piedboeuf, B., Hall, S., Rhodes, G.C., Niu, G., Fein, A.F., Horowitz, S. Cell Death Differ. (1997) [Pubmed]
  2. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. Selwyn, P.A., Feingold, A.R., Hartel, D., Schoenbaum, E.E., Alderman, M.H., Klein, R.S., Friedland, G.H. AIDS (1988) [Pubmed]
  3. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting. Chaisson, R.E., Stanton, D.L., Gallant, J.E., Rucker, S., Bartlett, J.G., Moore, R.D. AIDS (1993) [Pubmed]
  4. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. Chan, I.S., Neaton, J.D., Saravolatz, L.D., Crane, L.R., Osterberger, J. AIDS (1995) [Pubmed]
  5. Effect of systemic bacterial infection on absorption rates of L-histidine and glycylglycine from the human jejunum in vivo. Cook, G.C. Am. J. Clin. Nutr. (1977) [Pubmed]
  6. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. Hirschtick, R.E., Glassroth, J., Jordan, M.C., Wilcosky, T.C., Wallace, J.M., Kvale, P.A., Markowitz, N., Rosen, M.J., Mangura, B.T., Hopewell, P.C. N. Engl. J. Med. (1995) [Pubmed]
  7. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Ye, P., Rodriguez, F.H., Kanaly, S., Stocking, K.L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., Shellito, J.E., Bagby, G.J., Nelson, S., Charrier, K., Peschon, J.J., Kolls, J.K. J. Exp. Med. (2001) [Pubmed]
  8. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Graham, S.M., Mtitimila, E.I., Kamanga, H.S., Walsh, A.L., Hart, C.A., Molyneux, M.E. Lancet (2000) [Pubmed]
  9. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Hanly, P.J., Roberts, D., Dobson, K., Light, R.B. Lancet (1987) [Pubmed]
  10. A new therapeutic option for the treatment of pneumonia. McCabe, R., Chirurgi, V., Farkas, S.A., Haddow, A., Heinz, G., Greene, S. Am. J. Med. (1996) [Pubmed]
  11. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients. Morales, J.O., Snead, H. Am. J. Med. (1994) [Pubmed]
  12. Efficacy and safety of loracarbef in the treatment of pneumonia. Hyslop, D.L. Am. J. Med. (1992) [Pubmed]
  13. Pneumonia treated with imipenem/cilastatin. Salata, R.A., Gebhart, R.L., Palmer, D.L., Wade, B.H., Scheld, W.M., Groschel, D.H., Wenzel, R.P., Mandell, G.L., Duma, R.J. Am. J. Med. (1985) [Pubmed]
  14. Surfactant protein D expression in normal and pneumonic ovine lung. Grubor, B., Gallup, J.M., Ramírez-Romero, R., Bailey, T.B., Crouch, E.C., Brogden, K.A., Ackermann, M.R. Vet. Immunol. Immunopathol. (2004) [Pubmed]
  15. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. van der Sluijs, K.F., van Elden, L.J., Nijhuis, M., Schuurman, R., Pater, J.M., Florquin, S., Goldman, M., Jansen, H.M., Lutter, R., van der Poll, T. J. Immunol. (2004) [Pubmed]
  16. Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition. DeWitt, R.C., Wu, Y., Renegar, K.B., King, B.K., Li, J., Kudsk, K.A. Ann. Surg. (2000) [Pubmed]
  17. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Broug-Holub, E., Toews, G.B., van Iwaarden, J.F., Strieter, R.M., Kunkel, S.L., Paine, R., Standiford, T.J. Infect. Immun. (1997) [Pubmed]
  18. Expression and regulation of chemokines in bacterial pneumonia. Standiford, T.J., Kunkel, S.L., Greenberger, M.J., Laichalk, L.L., Strieter, R.M. J. Leukoc. Biol. (1996) [Pubmed]
  19. Interleukin-8 and granulocyte colony-stimulating factor in bronchoalveolar lavage fluid and plasma of human immunodeficiency virus-infected patients with Pneumocystis carinii pneumonia, bacterial pneumonia, or tuberculosis. Grünewald, T., Schüler-Maué, W., Ruf, B. J. Infect. Dis. (1993) [Pubmed]
  20. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. Greenberger, M.J., Strieter, R.M., Kunkel, S.L., Danforth, J.M., Goodman, R.E., Standiford, T.J. J. Immunol. (1995) [Pubmed]
  21. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. Amano, H., Morimoto, K., Senba, M., Wang, H., Ishida, Y., Kumatori, A., Yoshimine, H., Oishi, K., Mukaida, N., Nagatake, T. J. Immunol. (2004) [Pubmed]
  22. Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia. Morrison, D.F., Foss, D.L., Murtaugh, M.P. Infect. Immun. (2000) [Pubmed]
  23. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Matute-Bello, G., Frevert, C.W., Liles, W.C., Nakamura, M., Ruzinski, J.T., Ballman, K., Wong, V.A., Vathanaprida, C., Martin, T.R. Infect. Immun. (2001) [Pubmed]
  24. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. Jones, M.R., Quinton, L.J., Simms, B.T., Lupa, M.M., Kogan, M.S., Mizgerd, J.P. J. Infect. Dis. (2006) [Pubmed]
  25. Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group. Brown, R.B., Kruse, J.A., Counts, G.W., Russell, J.A., Christou, N.V., Sands, M.L. Antimicrob. Agents Chemother. (1990) [Pubmed]
  26. Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. Millar, A.B., Miller, R.F., Foley, N.M., Meager, A., Semple, S.J., Rook, G.A. Am. J. Respir. Cell Mol. Biol. (1991) [Pubmed]
  27. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages. Debon, R., Breilh, D., Boselli, E., Saux, M.C., Duflo, F., Chassard, D., Allaouchiche, B. Journal of chemotherapy (Florence, Italy) (2002) [Pubmed]
  28. Parapneumonic effusions and empyema. Light, R.W. Clin. Chest Med. (1985) [Pubmed]
  29. A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia. Petermann, W., Alegre-Martin, J., Odenholt, I., Phillips, M.J., Willcox, P.A., Tack, K., Trostmann, U., Welling, L. Scand. J. Infect. Dis. (2001) [Pubmed]
WikiGenes - Universities